Ashland reports financial results for fourth-quarter fiscal 20241, issues outlook for full-year fiscal 2025, provides portfolio optimization update and announces strategy update event
Financial results for fourth-quarter fiscal 20241 Sales of $522 million, up one percent from the prior-year quarter Sold nutraceuticals business […]